Literature DB >> 6299971

Insensitivity to interferon of two subclones of human endometrial carcinoma cell line, HEC-1.

N Morinaga, S Yonehara, Y Tomita, T Kuwata.   

Abstract

Two cloned cell lines, HEC-IC and HEC-ID, derived from the human endometrial adenocarcinoma cell line HEC-I, were found to be as resistant to the antiviral and anticellular activities of interferon (IFN) as were the parental cells, and 2'-5' oligoadenylate (2-5A) synthetase was not induced in these clones by IFN treatment. They were sensitive to the cytotoxicity of natural killer (NK) cells but their sensitivity was not changed by treatment of the cell lines with IFN. Binding of [3H]-leucine-labelled IFN-alpha to HEC-IC cells was examined, and Scatchard plot analysis showed that HEC-IC cells did not have any high-affinity binding sites for IFN-alpha. The cells had hyperploid chromosomes. HEC-IC had three copies of chromosome 21 while HEC-ID had only one copy of chromosome 21. The results suggest that these clones may have the structural gene for the IFN receptor but that functional receptor sites may be absent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299971     DOI: 10.1002/ijc.2910310105

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Downregulation of keratins 8, 18 and 19 influences invasiveness of human cultured squamous cell carcinoma and adenocarcinoma cells.

Authors:  A Uchiumi; M Yamashita; Y Katagata
Journal:  Exp Ther Med       Date:  2011-12-09       Impact factor: 2.447

2.  Isolation of estrogen-responsive genes with a CpG island library.

Authors:  T Watanabe; S Inoue; H Hiroi; A Orimo; H Kawashima; M Muramatsu
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

Review 3.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

4.  Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

Authors:  K Mitani; S Ogawa; T Tanaka; H Miyoshi; M Kurokawa; H Mano; Y Yazaki; M Ohki; H Hirai
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.